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Abstract 
Background: Autistic people and those with high autistic traits are at high risk of experiencing suicidality. Yet, there 
are no suicidality assessment tools developed or validated for these groups.
Methods: A widely used and validated suicidality assessment tool developed for the general population (SBQ‑R), 
was adapted using feedback from autistic adults, to create the Suicidal Behaviours Questionnaire—Autism Spectrum 
Conditions (SBQ‑ASC). The adapted tool was refined through nine interviews, and an online survey with 251 autistic 
adults, to establish clarity and relevance of the items. Subsequently, 308 autistic, 113 possibly autistic, and 268 non‑
autistic adults completed the adapted tool online, alongside self‑report measures of autistic traits (AQ), camouflaging 
autistic traits (CAT‑Q), depression (PHQ‑9), anxiety (ASA‑A), thwarted belongingness and perceived burdensomeness 
(INQ‑15), lifetime non‑suicidal self‑injury, and the original version of the suicidality assessment tool (SBQ‑R). Analyses 
explored the appropriateness and measurement properties of the adapted tool between the groups.
Results: There was evidence in support of content validity, structural validity, internal consistency, convergent and 
divergent validity, test–retest validity, sensitivity and specificity (for distinguishing those with or without lifetime 
experience of suicide attempt), and hypothesis testing of the adapted tool (SBQ‑ASC) in each group. The structure of 
the SBQ‑ASC was equivalent between autistic and possibly autistic adults, regardless of gender, or use of visual aids to 
help quantify abstract rating scales.
Limitations: The samples involved in the development and validation of the adapted tool were largely female, and 
largely diagnosed as autistic in adulthood, which limits the generalisability of results to the wider autistic popula‑
tion. The SBQ‑ASC has been developed for use in research and is not recommended to assess risk of future suicide 
attempts and/or self‑harm. The SBQ‑ASC has been designed with and for autistic and possibly autistic adults, and is 
not appropriate to compare to non‑autistic adults given measurement differences between these groups.
Conclusions: The SBQ‑ASC is a brief self‑report suicidality assessment tool, developed and validated with and for 
autistic adults, without co‑occurring intellectual disability. The SBQ‑ASC is appropriate for use in research to identify 
suicidal thoughts and behaviours in autistic and possibly autistic people, and model associations with risk and protec‑
tive factors.
Keywords: Suicidality, Autism spectrum conditions, Autistic traits, Measurementproperties, Suicidal behaviours 
questionnaire, Measurement invariance
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Introduction
People diagnosed with autism (henceforth autistic peo-
ple1) are at significantly increased risk of experiencing 
suicidal thoughts and behaviours [3–5] and death by 
suicide [6–8], compared to non-autistic people. Autistic 
people who have experienced delay in autism diagnosis 
until adulthood show the highest estimates of lifetime 
suicidal thoughts (66%), and suicide attempt(s) (35–36%) 
[9, 10]. Many adults remain undiagnosed, given lack of 
adult autism diagnostic services and appropriate assess-
ment tools to identify autism in women [11]. Possible 
undiagnosed autism is also associated with increased 
risk of suicidality. For example, 45% of women with high 
autistic traits in the region of clinical concern for possi-
ble autism reported making a suicide plan, and 16% had 
attempted suicide [12]. 40.6% of those with a lifetime his-
tory of suicide attempt(s), without autism diagnosis or 
suspected autism, scored above the clinical cut-off for 
possible autism on a validated measure of autistic traits 
[13]. 11% of depressed patients [14] and 15% of women 
with Borderline Personality Disorder (BPD) [15] met 
diagnostic criteria for co-occurring autism, and suicide 
attempts were highest in those with co-occurring autism 
diagnoses across both groups.
Given that autistic and possibly autistic people are at 
high risk of suicidality, it is crucial that appropriate and 
valid assessment tools are available to accurately iden-
tify suicidal thoughts and behaviours in these groups. 
However, systematic reviews have shown that no suici-
dality assessment tool has yet been validated for autistic 
people in research or clinical practice [16, 17]. Assess-
ment tools are validated for certain purposes or circum-
stances, rather than being valid or invalid [16, 18]. Our 
aim was to develop a brief tool for use in research stud-
ies, rather than a brief risk assessment tool to predict 
future self-harm or suicide attempts in clinical practice. 
This decision was made because brief risk assessment 
tools are generally poor predictors of future self-harm 
or suicide attempts in clinical practice [19–21] and are 
therefore a “do not do” recommendation in current clini-
cal guidelines in the UK [22]. Autistic people and those 
who support them also prioritised understanding risk 
and protective factors for suicidal thoughts and behav-
iours, how models of suicide apply to autistic people, and 
whether the experience of suicidality is different in autis-
tic people [23, 24]. Addressing these community research 
priorities will require brief validated research tools. 
Additionally, answering these questions will provide cru-
cial information for clinical practice, such as potentially 
unique risk factors for suicide in autistic people which 
need to be included in new effective risk assessment and 
treatment strategies [23, 24].
A recent systematic literature review [16] identified a 
suicidality assessment tool developed for non-autistic 
people—the Suicidal Behaviours Questionnaire—Revised 
[25]—as a promising candidate tool to adapt for autistic 
people for use in research studies. This was because: a) 
the SBQ-R was identified as the most frequently used 
tool in previous research, with a large body of evidence 
showing consistent moderate to strong evidence in sup-
port of a range of measurement properties when used in 
general population research, comparable to longer and 
more expensive tools; b) having a short research tool like 
the SBQ-R would reduce participant burden in research 
studies aiming to identify suicidal thoughts and behav-
iours; c) the SBQ-R was free to use and to adapt, crucial 
for facilitating future suicide in autism research; and d) 
some items of the SBQ-R in their current form had useful 
and specific definitions (e.g. “rarely (1 time)”, which pre-
vious research suggests could be particularly useful for 
autistic people [16]. The SBQ-R assesses lifetime experi-
ence of suicidal thoughts, plans and attempts (item 1), 
frequency of suicidal thoughts in the past year (item 2), 
communication of suicide intent to others (item 3), and 
likelihood of attempting suicide someday in the future 
(item 4).
One study has explored how autistic adults interpret 
and respond to the SBQ-R compared to non-autistic 
adults [26]. An online survey gathered responses to 
the SBQ-R in 188 autistic and 183 non-autistic adults 
matched on age and gender to compare the structure 
of the tool between the groups, and a subsample of 15 
autistic adults were interviewed while completing the 
SBQ-R to explore how they interpreted and responded 
to the items. Results showed that the structure of the 
SBQ-R was significantly different in autistic compared 
to non-autistic adults, and autistic adults interpreted 
the items differently than intended by the scale develop-
ers. Specifically, autistic adults reported having difficulty 
communicating their suicide intent to others despite 
experiencing suicidality. Consistent with this, responses 
to item 3 (communication of suicidal intent) were less 
strongly associated with other items for autistic com-
pared to non-autistic adults. This suggests that com-
munication of suicidal intent to others is less strongly 
indicative of suicidality in autistic compared to non-
autistic adults. Autistic adults said that it was important 
to ask about the likelihood of future suicide attempt(s) 
(item 4), but it was impossible to answer such an abstract 
future question. Likelihood of future suicide attempt(s) 
1 We use identity first language (autistic community/people/person) to 
describe and talk about autism in the current paper, given that this is the most 
preferred language of the autistic community [1, 2]. We recognise and respect 
the wide range of terms and different individual preferences for describing 
autism, and that the language used to describe and talk about autism will con-
tinue to evolve over time.
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was more strongly associated with performance on other 
items in the autistic compared to the non-autistic group, 
which may indicate that autistic people are drawing more 
strongly on previous behaviour to inform their response. 
Autistic adults reported that item 2 did not capture 
the full range or intensity of suicidal thoughts over the 
past year, and difficulties with complex and imprecise 
response options across items, (e.g. did not want to/
really hoped to die; never/no chance at all). Results also 
suggested a worrying clinical picture, that autistic adults 
reported impulsively attempting suicide without a plan 
when the means to attempt suicide where present [26].
Taken together these findings suggest that the SBQ-R 
would benefit from adaptation to improve the clarity 
and relevance of the items to autistic adults. The cur-
rent study thus aimed to adapt the SBQ-R, incorporat-
ing feedback from autistic adults from the earlier study 
[26], and refining the adapted tool with additional inter-
views and an online survey. Subsequently, we assessed 
the appropriateness and measurement properties of the 
adapted Suicide Behaviours Questionnaire—Autism 
Spectrum Conditions (SBQ-ASC) in autistic adults in a 
new sample. A key issue in suicidality in autism research, 
is the lack of measurement tools available to assess and 
compare suicidality and associated risk markers between 
different groups. Given the high risk of suicidal behav-
iours in possibly autistic (but undiagnosed) adults, it is 
also important that the SBQ-ASC operates as intended 
in autistic people regardless of diagnosis. The current 
study therefore also assessed whether the structure of the 
adapted SBQ-ASC is measurement invariant (i.e. equiva-
lent), and thus comparable between autistic, possibly 
autistic and non-autistic adults, and explored the meas-
urement properties of the adapted tool in each group.
We hypothesised that autistic and possibly autis-
tic adults would self-report significantly higher levels 
of suicidal thoughts and behaviours on the SBQ-ASC 
compared to non-autistic adults, on each item and total 
scores. Given the lack of previous suicidality research 
including possibly autistic people, we explored whether 
and how rates of suicidality differed between autistic and 
possibly autistic adults. We also hypothesised that total 
scores on the SBQ-ASC would be significantly corre-
lated with risk markers for suicidality in autistic and non-
autistic people identified from previous research (autistic 
traits, camouflaging autistic traits, depression, anxiety, 
non-suicidal self-injury (NSSI), thwarted belonging-
ness and perceived burdensomeness) [27–35]. We also 
hypothesised that the SBQ-ASC would be more strongly 
correlated with the original version of the tool (given 
they both measure the same construct—suicidality), 
compared to other proximal risk markers for suicidality 
(e.g. thwarted belonging, perceived burdensomeness and 
mental health), which would in turn be more strongly 
correlated with the SBQ-ASC compared to more distal 
risk markers (e.g. autistic traits and camouflaging autis-
tic traits). Given that we expected the SBQ-ASC to more 
accurately capture experience of suicidality relevant 
to autistic people, we also predicted that the SBQ-ASC 
would be more strongly correlated with autism relevant 
constructs (e.g. autistic traits, camouflaging autistic traits 
and measures developed for autistic people), compared 
to the original version of the tool. Lastly, given previ-
ous findings that autistic people might be more likely 
to impulsively attempt suicide without a plan, and have 
difficulties communicating their suicidal intent to oth-
ers, we predicted that autistic and possibly autistic adults 
would be significantly more likely to endorse these sub-




The research received a favourable ethical opinion from 
the relevant local Research Ethics Committee (ethics 
approval references P47603 and F1074).
Participants
The autistic group comprised 308 adults (27% male gen-
der) who self-reported a diagnosis of ASC from a trained 
clinician. The possibly autistic group comprised 113 
adults (29% male gender) who self-reported that they 
suspected they were autistic but had not yet been diag-
nosed. The non-autistic group comprised 268 adults (31% 
male gender) who reported that they were not diagnosed 
autistic or suspected they might be autistic. The autis-
tic and possibly autistic groups were significantly more 
likely to identify with a different gender than assigned 
at birth (16.3%) compared to the non-autistic group 
(3%) (X2(1) = 28.79, p < 0.001; OR 6.24 CI 2.95–13.21). 
There was no significant difference in age between the 
three groups (F(688) = 1.34, p = 0.263). Self-reported 
autistic traits (AQ Scores) were significantly different 
between the three groups (F(682) = 601.59, p < 0.001). 
Bonferroni corrected t tests showed that the autistic 
group self-reported significantly higher autistic traits 
(mean = 22.86, SD = 3.76) compared to the possibly 
autistic (mean = 20.17, SD = 4.57) and non-autistic group 
(mean = 9.45, SD = 5.67), and the possibly autistic group 
self-reported significantly higher autistic traits than the 
non-autistic group (all p < 0.001) (Table 1).
The autistic and possibly autistic groups were recruited 
through the Cambridge Autism Research Database, the 
Autistica network, and social media. The non-autistic 
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Table 1 Participant characteristics




N = 308 N = 113 N = 421 N = 268
N (%)/mean (SD)
Questionnaires AQ 22.86 (3.76) 20.17 (4.57) 22.14 (4.16) 9.45 (5.67)
CAT‑Q 129.02 (23.97) 123.5 (21.11) 127.56 (23.34) 83.31 (25.97)
Thwarted belongingness 36.84 (10.65) 35.71 (10.81) 36.53 (10.69) 23.09 (11.26)
Perceived burdensomeness 19.17 (9.21) 16.69 (8.51) 18.5 (9.09) 10.21 (5.68)
ASA‑A 37.82 (10.74) 32.49 (11.24) 36.4 (11.11) 19.35 (11.18)
PHQ‑9 14.29 (7.58) 12.92 (7.28) 13.92 (7.52) 7.37 (6.47)
Demographics Sex 82 (26.62) 29 (25.66) 111 (26.37) 85 (31.72)
Gender 83 (26.95) 33 (29.2) 116 (27.55) 83 (30.97)
Identify with a different gender than 
birth sex
51 (16.56) 17 (15.04) 68 (16.15) 8 (2.99)
Age (years) 39.71 (13.34) 40.34 (13.55) 39.88 (13.81) 41.57 (14.05)
UK residency 243 (78.9) 73 (64.6) 316 (75.06) 182 (67.91)
Ethnicity Asian 6 (1.95) 5 (4.42) 11 (2.61) 6 (2.24)
Black or African or Caribbean 2 (0.65) 3 (2.65) 5 (1.19) 3 (1.12)
Latinx 0 (0) 0 (0) 0 (0) 0 (0)
Middle eastern or arab 2 (0.65) 0 (0) 2 (0.48) 2 (0.75)
White or Caucasian 287 (93.18) 99 (87.61) 386 (91.69) 247 (92.16)
Other ethnic group 12 (3.9) 5 (4.42) 17 (4.04) 10 (3.73)
Prefer not to answer 2 (0.65) 2 (1.77) 4 (0.95) 1 (0.37)
Living arrangements Living with flatmate(s) 9 (2.92) 9 (7.96) 18 (4.28) 15 (5.6)
Living independently 88 (28.57) 23 (20.35) 111 (26.37) 50 (18.66)
Living with a partner and/or 
dependent(s)
131 (42.53) 60 (53.1) 191 (45.37) 179 (66.79)
Living with parents 55 (17.86) 11 (9.73) 66 (15.68) 20 (7.46)
Living with friend(s) 7 (2.27) 5 (4.42) 12 (2.85) 2 (0.75)
Living with a carer 1 (0.32) 1 (0.88) 2 (0.48) 0 (0)
Living in supported accommodation 0 (0) 0 (0) 0 (0) 0 (0)
Other 14 (4.55) 3 (2.65) 17 (4.04) 2 (0.75)
Employment status Employed full time 93 (30.19) 47 (41.59) 140 (33.25) 154 (57.46)
Employed part time 66 (21.43) 19 (16.81) 85 (20.19) 51 (19.03)
Volunteering full time 1 (0.32) 1 (0.88) 2 (0.48) 1 (0.37)
Volunteering part time 32 (10.39) 7 (6.19) 39 (9.26) 12 (4.48)
Student full time 36 (11.69) 18 (15.93) 54 (12.83) 28 (10.45)
Student part time 33 (10.71) 7 (6.19) 40 (9.5) 14 (5.22)
Retired 14 (4.55) 6 (5.31) 20 (4.75) 21 (7.84)
Unemployed looking for work 11 (3.57) 9 (7.96) 20 (4.75) 7 (2.61)
Unemployed not looking for work 10 (3.25) 10 (8.85) 20 (4.75) 7 (2.61)
Unable to work due to illness or dis‑
ability
90 (29.22) 18 (15.93) 108 (25.65) 7 (2.61)
Education Home 11 (3.57) 1 (0.88) 12 (2.85) 4 (1.49)
Mainstream 296 (96.1) 107 (94.69) 403 (95.72) 259 (96.64)
Special 12 (3.9) 1 (0.88) 13 (3.09) 2 (0.75)
Other 8 (2.6) 6 (5.31) 14 (3.33) 7 (2.61)
University degree 206 (66.88) 79 (69.91) 285 (67.7) 221 (82.46)
ASC subtype Asperger syndrome 150 (48.7)
High functioning autism 29 (9.42)
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group was recruited through the Cambridge Psychology 
Research Database and social media channels.
Measures
Suicide behaviours questionnaire—autism spectrum 
conditions
Figure 1 shows the stages involved in the overall develop-
ment and validation of the SBQ-ASC with and for autis-
tic adults. The SBQ-ASC was adapted from the SBQ-R 
with permission of the tool developers [25]. A previous 
study had explored how autistic compared to non-autistic 
adults interpret and respond to the SBQ-R [26], to inform 
how to adapt this tool for autistic adults. The adapted 
SBQ-ASC was subsequently refined through: a) Cogni-
tive interviews with 9 autistic adults (who took part in 
the earlier study, [26]); and b) A survey completed by 251 
autistic and possibly autistic adults who provided quali-
tative feedback, and rated the clarity and importance of 
each item of the original SBQ-R and adapted SBQ-ASC 
(234 diagnosed, 17 awaiting assessment; 30.7% male; 
mean age = 41.91, SD = 13.44; mean age of ASC diag-
nosis = 36.09, SD = 14.03; 61.4% Asperger Syndrome 
Table 1 (continued)




N = 308 N = 113 N = 421 N = 268
N (%)/mean (SD)
Atypical autism 1 (0.32)
Autism 32 (10.39)
ASC 60 (19.48)
Classic autism 2 (0.65)
PDD‑NOS 1 (0.32)
Other 30 (9.74)
Age of ASC diagnosis 34.58 (14.12)
Clinician confirmed 308 (100)
Developmental conditions  >  = 1 Co‑occurring Developmental 
Condition
86 (27.92) 16 (14.16) 102 (24.23) 26 (9.7)
Dyspraxia 24 (7.79) 4 (3.54) 28 (6.65) 5 (1.87)
Learning disability 3 (0.97) 2 (1.77) 5 (1.19) 1 (0.37)
Learning difficulty 1 (0.32) 0 (0) 1 (0.24) 0 (0)
Dyscalculia 6 (1.95) 0 (0) 6 (1.43) 2 (0.75)
Dyslexia 25 (8.12) 2 (1.77) 27 (6.41) 10 (3.73)
ADHD 42 (13.64) 9 (7.96) 51 (12.11) 15 (5.6)
Developmental delay 5 (1.62) 0 (0) 5 (1.19) 0 (0)
Other 10 (3.25) 0 (0) 10 (2.38) 1 (0.37)
Current mental health/other condi‑
tions
 >  = 1 current mental health/other 
condition
220 (71.43) 61 (53.98) 281 (66.75) 86 (32.09)
Depression 154 (50) 45 (39.82) 199 (47.27) 64 (23.88)
Anxiety 184 (59.74) 50 (44.25) 234 (55.58) 57 (21.27)
OCD 29 (9.42) 3 (2.65) 32 (7.6) 5 (1.87)
Bipolar 14 (4.55) 3 (2.65) 17 (4.04) 3 (1.12)
Personality disorder 20 (6.49) 9 (7.96) 29 (6.89) 8 (2.99)
Schizophrenia 0 (0) 0 (0) 0 (0) 1 (0.37)
PTSD 55 (17.86) 15 (13.27) 70 (16.63) 8 (2.99)
Tourette’s syndrome/tic disorder 6 (1.95) 0 (0) 6 (1.43) 1 (0.37)
Anorexia 12 (3.9) 1 (0.88) 13 (3.09) 2 (0.75)
Bulimia 5 (1.62) 1 (0.88) 6 (1.43) 3 (1.12)
Other 30 (9.74) 5 (4.42) 35 (8.31) 4 (1.49)
AQ = Autism Spectrum Quotient; CAT-Q = Camouflaging Autistic Traits Questionnaire; TB = Thwarted Belonging; PB = Perceived Burdensomeness; ASA-A = Anxiety 
Scale for Autistic Adults; PHQ-9 = Patient Health Questionnaire—9 Items; ASC = Autism Spectrum Condition; PDD-NOS = Pervasive Developmental Disorder—not 
otherwise specified; ADHD = Attention Deficit and Hyperactivity Disorder; OCD = Obsessive Compulsive Disorder; PTSD = Post Traumatic Stress Disorder
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diagnosis). Table  2 summarises the key issues identified 
with the SBQ-R by autistic adults across the interviews 
and online survey, and the subsequent adaptations incor-
porated into the SBQ-ASC to address these.
The penultimate version of the SBQ-ASC items tested 
in the online survey was rated as “clear” by at least 79% of 
the 251 autistic/possibly autistic participants, and mean 
importance ratings ranged from 74.17 to 84.93 (out of 
100) for each item (mean = 78.89, SD = 3.99). After minor 
corrections to grammar and wording to improve clar-
ity, the final version of the SBQ-ASC used in the current 
study was given an overall mean clarity rating of 82.72 
(out of 100, SD = 22.9) by the combined autistic/possibly 
autistic group, and 88.05 (SD = 21.13) by the non-autistic 
group. Analysis of the qualitative feedback across the two 
surveys showed that the issues identified with the penul-
timate version of the SBQ-ASC assessed in the earlier 
survey had been successfully addressed in the final ver-
sion of the tool used in the current study.
The SBQ-ASC has five scored items (Table  2). Item 
1 assesses lifetime experience of suicidal thoughts and 
behaviours from “Never” (0) to “I have attempted to 
end my life” (4). Item 2 assesses frequency of intense 
suicidal thoughts in the last 12  months from “Never” 
(0) to “1 or more times a day” (6). Item 3 assesses per-
severative intense suicidal thoughts from “Not Appli-
cable” (0), “Less than 5  min” (1) to “More than 8  h” 
(5). Item 4 assesses likelihood of suicide attempt from 
“Not Applicable” (0), “No chance at all” (1) to “Very 
likely” (5). It is recommended that a visual aid, such 
as a measuring jug or thermometer, is offered to par-
ticipants to help quantify each response option for 
item 4 if they think this could be useful to them. Item 
5 assesses communication of future suicide intent and 
past suicide attempts to others. Responses are scored 
from “Not applicable” (0)/“No” (0), to “Yes, once”/“Yes 
more than once”. Endorsing either “Yes” item is scored 
1 for suicidal thoughts, 2 for future suicide attempts, 
and 3 for past suicide attempts. Participants can 
endorse all the options giving a maximum score of 6 
for item 5.
Optional follow-up items which are not scored are 
also included in the SBQ-ASC. For those who endorse 
lifetime suicide attempt, these items address presence 
of plans, impulsivity and access to means. For those 
who have communicated suicidality to others, follow-
up items gather information on who was told (e.g. 
friend, family member or professional). For those who 
have never told anyone about their suicidality, follow-
up items gather information on why (e.g. I had no one 
to tell, I was afraid to). Item 6 also captures lifetime 
experience of non-suicidal self-injury, “Have you ever 
purposefully injured yourself, without intending to end 
your life? Yes/No. Therefore, alongside item 1, the SBQ-
ASC can be used to classify lifetime experience of self-
harm, with or without intent to end life.
Fig. 1 Stages of the overall research program to identify, develop and validate the SBQ‑ASC from the original tool (SBQ‑R)
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Suicide behaviours questionnaire—revised (SBQ‑R)
The SBQ-R [25] is a four-item self-report questionnaire 
measuring suicidality. Item 1 assesses lifetime suicidal 
behaviour (on a scale from “Never” to “I have attempted 
to kill myself, and really hoped to die”). Item 2 assesses 
suicide ideation over the past 12  months (on a scale 
from “Never” to “Very Often (5 or more times)”). Item 3 
assesses communication of suicidal intent to others (on 
a scale from “No” to “Yes, more than once, and really 
wanted to do it”). Item 4 assesses likelihood of a suicide 
attempt someday in the future (on a scale from “Never” 
to “Very likely”). The SBQ-R has been validated for use in 
general population samples to reliably distinguish people 
who have, from people who have not attempted suicide 
[25, 36]. The SBQ-R is widely used in research with mod-
erate-strong evidence in support of internal consistency, 
structural validity, and criterion validity in research with 
general population samples [16]. The SBQ-R has also 
been utilised in research with autistic adults [e.g. 3,34], 
with evidence that the structure and interpretation of the 
SBQ-R is different in autistic compared to non-autistic 
adults [26]. Cronbach’s alpha for whole scale: Autistic 
group α = 0.739, possibly autistic group α = 0.755, non-
autistic group α = 0.734.
Autism spectrum quotient—short (AQ‑S)
The AQ-short [37] is a 28-item subset of the full 50 item 
Autism Spectrum Quotient [38]. The AQ-28 measures 
the number of self-reported autistic traits, with high 
scores indicating more autistic traits. Items such as ‘it 
does not upset me if my daily routine is disturbed’ and 
‘I find it easy to work out what someone is thinking or 
feeling’ are rated on a 4-item response scale from 1 “defi-
nitely agree” to 4 “definitely disagree” [37]. In the current 
study, responses endorsing autistic traits were given a 
score of 1, giving a total range from 0–28. A systematic 
review showed satisfactory evidence in support of the 
AQ-S factor structure, internal consistency, test–retest 
reliability and convergent validity as rated by a validated 
research tool (COSMIN) [39]. Using the dichotomous 
scoring method, scores at or above a clinical cut-off of 16 
have showed acceptable sensitivity and specificity in dis-
tinguishing autistic from non-autistic adults [40]. Cron-
bach’s alpha for whole scale: Autistic group α = 0.765, 
possibly autistic group α = 0.791, non-autistic group 
α = 0.854.
Camouflaging autistic traits questionnaire (CAT‑Q)
The Camouflaging Autistic Traits Questionnaire (CAT-
Q) is a 25-item self-report questionnaire assessing the 
extent to which a person engages in social camouflaging 
behaviours, validated in autistic and non-autistic adults 
with equivalent factor structure between the groups [41]. 
The CAT-Q captures three domains of social camouflag-
ing: (1) “compensation” (behaviours used to compensate 
for autism-related difficulties in social situations); (2) 
“masking” (behaviours used to hide autistic character-
istics or present a non-autistic personality to others); 
and (3) “assimilation” (behaviours used to fit in better 
with others and not “stand out” from the crowd). Par-
ticipants rate each of the 25 questions on a seven-point 
Likert scale between “Strongly Agree” to “Strongly Disa-
gree”. Responses are scored between 1 and 7, with higher 
scores for items which endorse presence of social cam-
ouflaging behaviour. Cronbach’s alpha for whole scale: 
Autistic group α = 0.919, possibly autistic group α = 0.9, 
non-autistic group α = 0.931.
Anxiety scale for autism (Adults) (ASA‑A)
The ASA-A [42] is a 20-item self-report measure of anxi-
ety designed with and for autistic adults, adapted from 
the Anxiety Scale for Autism Spectrum Disorder (ASC-
ASD). The ASA-A measures four components of anxiety: 
Social Phobia (e.g. ‘I worry what other people think of 
me’), Anxious Arousal (e.g. ‘All of a sudden I feel really 
scared’), and Uncertainty (e.g. ‘I am anxious about unfa-
miliar things, people or places’). Each item is rated on a 
scale from “Never” (0)—“Always” (3), with total scores 
ranging from 0–60. Scores at or above 28 indicate clini-
cally significant levels of [42]. The ASA-A has strong 
evidence in support of its measurement properties (fac-
tor structure, internal consistency, test–retest reliabil-
ity, convergent and divergent validity) in autistic adults 
[42]. Cronbach’s alpha for whole scale: Autistic group 
α = 0.921, possibly autistic group α = 0.926, non-autistic 
group α = 0.943.
Patient health questionnaire—9 Item (PHQ‑9)
The Patient Health Questionnaire-9 item (PHQ-9) [43] is 
a 9-item self-report scale used to assess severity of cur-
rent depressive symptoms in line with DSM-V diagnos-
tic criteria [44]. Scores range from 0 to 27 with scores at 
or over 10 indicating moderate, 15 moderately severe, 
and 20 severe depression. A recent systematic review 
showed that the PHQ-9 was extensively used in general 
population research, with strong evidence for its psycho-
metric properties as rated by a validated research tool 
(COSMIN) [45], and more recently, evidence in sup-
port of total scores being comparable between autistic 
and non-autistic adults [46]. Cronbach’s alpha for whole 
scale: Autistic group α = 0.907, possibly autistic group 
α = 0.904, non-autistic group α = 0.909.
Interpersonal needs questions—15 item (INQ‑15)
The Interpersonal Needs Questionnaire (INQ-15) is a 
15-item self-report questionnaire assessing ‘thwarted 
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belongingness’ (e.g. ‘These days, I often feel like an out-
sider in social gatherings’) and ‘perceived burdensome-
ness’ (e.g. ‘These days, I think I am a burden on society’) 
[47]. The INQ-15 has been validated in young non-autis-
tic adults [47] and has been used in previous research 
with autistic adults and those with high autistic traits 
[27, 33, 34, 48]. Cronbach’s alpha for whole scale: Autistic 
group α = 0.927, possibly autistic group α = 0.933, non-
autistic group α = 0.936.
Demographics
Participants were asked to report on their age, sex, gen-
der, employment, education, living situation, diagnoses 
(developmental, mental health and other), ASC diagnosis 
(clinically confirmed, suspected but not yet unconfirmed, 
and not autistic or suspected to be autistic), and for those 
with clinically confirmed diagnosis, the age of ASC diag-
nosis and the type of professional they were diagnosed by 
(e.g. paediatrician, psychologist, psychiatrist).
Procedure
Participants were invited to complete an online survey 
using Qualtrics aiming to adapt mental health assessment 
tools for autistic adults. Participants were informed that 
anyone 18-years or over could participate, regardless of 
autism diagnosis, experience of mental health problems 
or suicidal thoughts or behaviours. Participants were fully 
briefed about the nature of the research, that they could 
skip questions and sections of the survey that made them 
feel uncomfortable, stop the survey at any time and com-
plete it later. Participants were also provided information 
about relevant support services before taking part in the 
study, after each section of the study, and after taking 
part in the study in a downloadable debrief sheet. After 
providing consent, participants completed the demo-
graphics questions, AQ-S, CAT-Q, INQ-15, ASA-A, 
PHQ-9, SBQ-R and SBQ-ASC. The order of the SBQ-R 
and SBQ-ASC were randomised between participants. 
Participants were then asked for consent to complete the 
SBQ-R and SBQ-ASC again in two weeks. Subsequently 
participants were provided with a full debrief including 
information about further information and support, fol-
lowed by a positive mood induction procedure (a doodle 
page with jokes, puzzles and cute animal videos) which 
has proved effective in previous research exploring simi-
lar topics [49].
Analyses
The autistic and non-autistic samples were split in two, 
stratified by gender and age. The first half was utilised 
in the exploratory factor analysis (‘exploratory sam-
ple’ n = 285, consisting of n = 153 autistic and n = 132 
non-autistic adults), and the second half utilised in the 
confirmatory factor analysis (‘confirmatory sample’ 
n = 291, consisting of n = 155 autistic and n = 136 non-
autistic adults). The two samples did not significantly 
differ in age (partial η2 = 0.001), autistic traits (partial 
η2 = 0.001), birth sex (OR = 0.84) or gender (Cramer’s 
V = 0.008). The confirmatory factor analysis model in the 
autistic group was subsequently tested in the whole pos-
sibly autistic group (n = 113). Analyses were conducted 
in SPSS version 26 and measurement invariance analysis 
conducted in SPSS AMOS version 24. 1319 participants 
initially accessed the survey. Of these, 748 participants 
who met eligibility criteria opted to see the SBQ-ASC 
questions, 689 (92.11%) of these participants completed 
all SBQ-ASC items with no missing data, and 686 also 
completed at least one additional measure with no miss-
ing items. Only measures with complete data for all items 
were included in the analysis. Prior to analysis, data for 
each measure were also screened for valid responses. 
This included checking that responses across questions 
were consistent (e.g. free text responses which addressed 
the question, that presence of lifetime suicidal thoughts 
were consistent across the SBQ-R and SBQ-ASC, and 
those who reported no lifetime suicidality also did not 
report suicidal thoughts in the past year etc.).
Exploratory factor analysis of the SBQ-ASC
Principle components analyses were performed on the 
exploratory half of the autistic (n = 153), and non-autis-
tic (n = 132) subsamples, and both the autistic and non-
autistic groups combined (n = 285). The sample size was 
sufficient for EFA, with over 7 participants per item, 
and over 100 participants total [50]. Items with loadings 
below 0.4, or with cross-loadings of greater than 0.4 were 
excluded [51].
Confirmatory factor analysis
The Chi-square statistic was used an indicator of fit 
[52], alongside other fit indices given that chi-square is 
affected by sample size [53]. The χ2/df ratio should be 
close to zero [54], root mean square of approximation 
(RMSEA) close to 0.06 [55], the comparative fit index 
higher than 0.9 [56], and Tucker-Lewis Index (TLI) 
values over 0.9 [52]. CFA was conducted on the con-
firmatory half of the autistic (n = 155), and non-autistic 
(n = 136) subsamples. The model identified in the autis-
tic group was then tested in the whole possibly autistic 
group (n = 113). Groups that showed acceptable fit to the 
same model were combined, and the model re-run to test 
fit in the combined sample(s). Sample size was sufficient 
for CFA (> 7 participants per item, and > 100 participants 
total) [50].
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Measurement invariance
The exploratory and confirmatory samples were re-
combined, and multi-group confirmatory factor analysis 
used to determine whether the SBQ-ASC had a similar 
structure between the groups: autistic (n = 308), pos-
sibly autistic (n = 113) and non-autistic (n = 268). Data 
was combined across groups which showed evidence for 
measurement invariance. Further analysis subsequently 
explored whether the structure was equivalent in males 
and females, and those who did and did not request vis-
ual aids for item 5 of the SBQ-ASC.
Measurement invariance analysis tests a series of 
nested models, with increasingly strict constraints, to 
assess evidence for increasingly strict levels of measure-
ment invariance (i.e. equivalence) between groups [57, 
58]: 1) configural invariance tests whether sets of items 
measure the same latent variable in both groups; 2) met-
ric invariance tests whether the strength of the relation-
ship between items are the same for both groups; 3) 
scalar invariance tests whether the total scores result 
from similar responses to individual items across groups; 
4) residual invariance tests whether scale items measure 
the latent constructs with the same amount of meas-
urement error across groups. In order to compare total 
scores from a measure between different groups, evi-
dence for scalar invariance must be shown across the 
groups, as this suggests that total scores on the meas-
ure consists of similar performance on individual items 
[57]. Increase in RMSEA (> 0.015) and reduction in CFI 
(> 0.01) at each level were used as indicators of a signifi-
cant degradation in fit, given that the chi-square statistic 
is strongly influenced by sample size [59].
Reliability and validity
In each group, internal consistency was measured using 
Chronbach’s alpha for total scores. Spearman’s cor-
relations, intraclass coefficient, and ANOVA assessed 
test–retest reliability of SBQ-ASC total scores between 
time one and time two in each group. Spearman’s cor-
relations also assessed convergent validity between the 
SBQ-ASC with the original version of the tool (SBQ-R), 
and other measures of autistic traits (AQ), anxiety (ASA-
A), depression (PHQ-9), lifetime NSSI (item 6 of the 
SBQ-ASC), thwarted belongingness and perceived bur-
densomeness (INQ-15). Divergent validity was assessed 
using z-tests to compare the strength of the correlation 
coefficients. Specifically: a) whether the SBQ-ASC was 
more strongly correlated with autism relevant constructs 
(AQ, CAT-Q and ASA-A) compared to the original ver-
sion of the tool (SBQ-R); b) whether the correlation 
between the SBQ-ASC with the original version of the 
tool (SBQ-R) was larger compared to other proximal risk 
markers for suicide (thwarted belongingness, perceived 
burdensomeness, depression and anxiety); and c) 
whether the SBQ-ASC was more strongly correlated with 
more proximal mental health risk markers for suicide 
(depression and anxiety) compared to more distal risk 
markers (autistic traits and camouflaging autistic traits).
Receiver Operating Curve (ROC) analysis was used 
to establish an indicative cut-off score for the SBQ-ASC 
discriminating those who have from those who have not 
attempted suicide in their lifetime (using item 1 of the 
SBQ-R as the criterion). Kruskal Wallis analyses com-
pared the SBQ-ASC items between groups, and total 
scores between groups (with evidence of measurement 
invariance at the scalar or residual level). Significant main 
effects were followed up with Mann Whitney U to test 
focused comparisons with partial eta squared calculated 
as a measure of effect size. Chi-square analyses compared 
frequency of sub-questions probing characteristics of 
suicidality, NSSI and above cut-off scores between the 
groups, with phi calculated as an estimate of effect size 
for multiple group comparisons, and odds ratios cal-
culated as a measure of effect size for focused compari-




Table 3 shows the results of the EFA which indicates evi-
dence for a one-factor solution (with all items loading 
above 0.4), explaining 57.86% of the variance in the autis-
tic, 63.06% variance in the non-autistic group and 65.39% 
of the variance in both groups combined. All items of the 
SBQ-ASC were therefore retained.
Confirmatory factor analysis
Examination of modification indices in the autistic 
and possibly autistic groups indicated that co-varying 
the error terms for conceptually related items 1 and 5 
improved the fit of the model (1), whereas for the non-
autistic group, co-varying error terms for items 3 and 
5, and 4 and 5 improved the fit of the model (2) (Fig. 2). 
After co-varying the respective error terms, each group 
showed good fit to the model (Table 4).
Measurement invariance analysis
Measurement invariance between the autistic and pos-
sibly autistic groups was tested, given the similar CFA 
model (1) identified in each of these groups separately 
and combined (Fig.  2 and Table  4). There was evi-
dence for metric and scalar, but not residual invari-
ance between the autistic and possibly autistic groups 
(Table 5). This suggests that the SBQ-ASC total scores 
can be compared between autistic and possibly autis-
tic adults, and therefore data from these groups were 
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combined in subsequent measurement invariance 
analyses. Measurement invariance analysis was not 
undertaken to compare the combined autistic/possi-
bly autistic group to the non-autistic group, given the 
evidence for different baseline models in these groups 
(Fig. 2).
Measurement invariance analysis therefore compared 
gender (males and females), and use of visual aids for 
item 4 of the SBQ-ASC, in the combined autistic/pos-
sibly autistic group, and separately in the non-autistic 
group. Analyses showed evidence for measurement 
invariance at the metric and scalar level when com-
paring gender in the combined autistic/possibly autis-
tic group, and the non-autistic group, and evidence 
for measurement invariance at the metric, scalar and 
residual levels for the use of visual aids in the combined 
autistic/possibly autistic group, and the non-autistic 
group (Table 6).
Reliability and validity
Reliability and validity of the 5-item SBQ-ASC scale 
were explored in the combined sample of autistic/pos-
sibly autistic adults (n = 421), and non-autistic adults 
(n = 268), who had completed the SBQ-ASC and at least 
one other measure.
Internal consistency
Acceptable internal consistency was found for the total 
scale in the combined autistic/possibly autistic group 
(0.792) and the non-autistic group (0.848).
Test–retest reliability
All participants were invited to complete the SBQ-ASC 
two weeks after completing the first survey. Test–retest 
reliability was calculated in a sub-sample of autistic/pos-
sibly autistic participants (n = 172), and non-autistic par-
ticipants (n = 72), who completed the SBQ-ASC 2-weeks 
Fig. 2 CFA models of the SBQ‑ASC in the combined autistic/possibly autistic group, and the non‑autistic group.
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Table 2 Summary of feedback across the cognitive interviews and survey on the SBQ‑R and subsequent adaptations to the SBQ‑ASC
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after completing the initial survey. This sub-sample con-
sisted of all participants who consented to complete the 
follow-up, and who completed all items of the SBQ-ASC 
at time one and time two. In the autistic/possibly autistic, 
and non-autistic groups, there were no significant differ-
ences in age, sex ratio, rate of any development or mental 
health condition, or questionnaire scores (AQ, CAT-Q, 
INQ-10, ASA-A, PHQ-9, SBQ-R) between participants 
who completed the SBQ-ASC at time one, compared 
to those who completed the SBQ-ASC at time one and 
time two (see Additional file  1 for results of all group 
comparisons).
Time one and time two SBQ-ASC scores were strongly 
correlated in the combined autistic/possibly autistic 
group (rs = 0.927) and the non-autistic group (rs = 0.902), 
with high intra-class correlations (autistic/possible 
Table 3 Item level factor loadings for the exploratory factor analysis in the autistic and non‑autistic groups (exploratory sample)









1. Have you ever thought about or attempted to end your life? .817 .833 .854
2. How often on average have you experienced intense thoughts about ending your life in the past 
12 months?
.692 .591 .715
3. When you have intense thoughts about ending your life, how long per day does this typically last? .746 .869 .827
4. When you experience intense thoughts about ending your life, how likely are you to act on them? .84 .878 .883
5. Have you ever told anyone that you: were thinking about ending your life/were going to attempt to 
end your life/had attempted to end your life?
.696 .764 .752
Cronbach’s Alpha .818 .848 .85
Table 4 Model fit of confirmatory factor analysis in separate and combined groups (confirmatory sample)
Recommended goodness of fit indices values demonstrating good model fit: χ2/df ratio close to zero (Bryant & Yarnold, 1995), RMSEA < 0.06, CFI > 0.95 and TLI > 0.9 
(Browne, 2014; Hu & Bentler, 1993). Model 0 indicates baseline models without covaried error terms. Model 1 covaried error terms for items 1 + 5; Model 2 covaried 
error terms for items 3 + 4, and items 3 + 5 (Fig. 2)
Model Model N Χ2 df Χ2/df ratio p RMSEA CFI TLI
Autistic 0 155 35.92 5 7.18 .001 .2 .915 .829
Autistic 1 155 6.4 4 1.6 .171 .062 .993 .983
Possibly autistic 0 113 22.59 5 4.52 .001 .177 .924 .847
Possibly autistic 1 113 2.88 4 .721 .578 .001 1 1.01
Combined autistic/possibly autistic 0 268 52.46 5 10.49 .001 .189 .925 .85
Combined autistic/possibly autistic 1 268 4.36 4 1.09 .359 .018 .999 .999
Non‑autistic 0 136 32.34 5 6.47 .001 .201 .927 .853
Non‑autistic 1 136 18.32 4 4.58 .001 .163 962 .904
Non‑autistic 2 136 2.87 3 .96 .412 .001 1 1.001
Table 5 Results of tests for measurement invariance in SBQ‑ASC across the diagnosed autistic and possibly autistic adult groups
RMSEA = Root-mean-square error of approximation. CFI = comparative fit index. TLI = Tucker-Lewis Index
1 Marginally significant degradation in fit is seen after this model (increase in RMSEA > .015 and reduction in CFI > .01)
Model Χ2 df Model fit CFI TLI ΔM Model difference P
RMSEA Δdf Δχ2
M1: configural invariance 
(unconstrained)
7.56 8 .001 1 1.001 .478
M2: metric invariance 10.53 11 .001 1 1.001 M2–M1 3 2.97 .396
1M3: scalar invariance 11.67 12 .001 1 1.001 M3–M2 1 1.14 .286
M4: residual invariance 26.07 16 .039 .988 .985 M4–M3 4 14.41 .006
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autistic ICC = 0.928, 95% CI 0.9–0.946; non-autistic 
ICC = 0.921, 95% CI 0.877–0.95). There was no signifi-
cant difference between SBQ-ASC total scores between 
time one and time two across both groups (F(242) = 1.34, 
p = 0.249), and no significant interaction between time 
points and group (F(242) = 2.3, p = 0.13).
Convergent validity
Spearman’s correlations were undertaken in the com-
bined autistic/possibly autistic group, and the non-
autistic group separately. SBQ-ASC total scores were 
significantly correlated with all measures in both groups 
and was highly correlated with the original version of the 
tool (SBQ-R) (Table 7).
Divergent validity
In the autistic/possibly autistic group, the ASA-A was 
significantly more strongly correlated with the SBQ-
ASC (rs = 0.46), than the SBQ-R (rs = 0.393) (z = 3.04, 
p < 0.001). There was no significant difference in the 
size of the correlation coefficient between the AQ/
CAT-Q with the SBQ-ASC compared to the SBQ-R 
(AQ rs = 0.164 vs. rs = 0.141, z = 0.95, p = 0.171; CAT-Q 
rs = 0.232 vs. rs = 0.197, z = 1.465, p = 0.071 respectively).
The SBQ-ASC was significantly more strongly cor-
related with the SBQ-R (rs = 0.877) than with thwarted 
belongingness (rs = 0.384) (z = 13.77, p < 0.001), perceived 
burdensomeness (rs = 0.631) (z = 10.76, p < 0.001), PHQ-9 
(rs = 0.545) (z = 11.984, p < 0.001) and ASA-A (rs = 0.46) 
(z = 15.73, p < 0.001). The SBQ-ASC was significantly 
more strongly correlated with the PHQ-9 (rs = 0.545) 
than with the AQ (rs = 0.146) (z = 6.456, p < 0.001), 
and the CAT-Q (rs = 0.232) (z = 6.257, p < 0.001). The 
SBQ-ASC was significantly more strongly correlated 
with ASA-A (rs = 0.46) than with the AQ (rs = 0.164) 
(z = 3.123, p < 0.001), but not the CAT-Q (rs = 0.232) 
(z = 0.136, p = 0.446).
Sensitivity and specificity
ROC analysis showed that the SBQ-ASC had excellent 
sensitivity and specificity, with indicative cut-offs cor-
rectly classifying 88% of autistic adults who reported life-
time experience of suicide attempt(s) according to item 1 
of the SBQ-R (Table 8).
Hypothesis testing
Table  9 includes response option endorsement, item 
means and mean total scores on the SBQ-ASC and 
Table 6 Results of tests for invariance in SBQ‑ASC across gender and visual aids in the combined autistic/possibly autistic group, and 
non‑autistic group
RMSEA = Root-mean-square error of approximation. CFI = comparative fit index. TLI = Tucker-Lewis index
1 Marginally significant degradation in fit is seen after this model (increase in RMSEA > .015 and reduction in CFI > .01)
Model Χ2 df Model fit CFI TLI ΔM Model difference P
RMSEA Δdf Δχ2
Comparison of gender (combined autistic/possibly autistic group)
M1: Configural invariance (unconstrained) 8.62 8 .015 .999 .998 .375
M2: Metric invariance 9.7 11 .001 1 1 M2–M1 3 1.08 .782
M3: Scalar invariance 11.03 12 .001 1 1 M3–M2 1 1.32 .25
M4: Residual invariance 12.02 16 .001 1 1.01 M4–M3 4 .999 .91
Comparison of visual aids (combined autistic/possibly autistic group)
M1: Configural invariance (unconstrained) 5.58 8 .001 1 1.01 .694
M2: Weak factorial/metric invariance 7.31 11 .001 1 1.01 M2–M1 3 1.73 .631
M3: Scalar invariance 7.45 12 .001 1 1.01 M3–M2 1 .147 .7
M4: Strict invariance 13.73 16 .001 1 1 M4–M3 4 6.27 .18
Comparison of gender (non-autistic group)
M1: Configural invariance (unconstrained) 19.38 6 .093 .98 .933 .004
M2: Weak factorial/metric invariance 23.68 9 .08 .978 .951 M2–M1 3 4.302 .231
1M3: Scalar invariance 24.28 10 .074 .979 .957 M3–M2 1 .595 .44
M4: Strict invariance 42.46 14 .089 .957 .939 M4–M3 4 18.18 .001
Comparison of visual aids (non-autistic group)
M1: Configural invariance (unconstrained) 15.01 6 .075 .987 .955
M2: Weak factorial/metric invariance 18.31 9 .062 .986 .969 M2–M1 3 3.297 .348
M3: Scalar invariance 18.41 10 .056 .987 .975 M3–M2 1 .105 .746
M4: Strict invariance 20.54 14 .042 .99 .986 M4–M3 4 2.132 .711
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results of all group comparisons between the autis-
tic, possibly autistic and non-autistic groups. Autistic 
adults scored significantly higher than possibly autistic 
and non-autistic adults, and possibly autistic adults sig-
nificantly higher than non-autistic adults, on items 1, 3, 
4 and 5 of the SBQ-ASC (all p < 0.01). On item 2 of the 
SBQ-ASC, autistic and possibly autistic adults scored 
significantly higher than non-autistic adults (all p < 0.01). 
Autistic adults total scores on the SBQ-ASC were sig-
nificantly higher than possibly autistic adults (η2 = 0.05). 
Autistic adults were also significantly more likely to score 
at or above the SBQ-ASC cut-off than possibly autistic 
adults (OR = 2.59) (p < 0.001).
Analysis of the optional sub-questions on the SBQ-
ASC were compared between autistic, possibly autistic, 
and non-autistic adults. In the subsample who reported 
lifetime experience of suicide attempt(s) (n = 162), 
there were no significant between groups differences 
in the characteristics of past suicide attempt(s) (plan-
ning, impulsivity, or access to means) (all p > 0.22). In 
the sub-group who reported past communication of sui-
cidal thoughts or behaviours to others (n = 344), there 
were no significant between group differences in who 
was disclosed to (acquaintance, friend, family member, 
professional or other) (all p > 0.21). In the sub-group 
who reported not having disclosed suicidal thoughts or 
behaviours to others (n = 259), compared to non-autis-
tic adults, autistic and possibly autistic adults were sig-
nificantly more likely to endorse “I was worried about 
the consequences for myself” (autistic vs. non-autistic 
OR = 2.96; possibly autistic vs. non-autistic OR = 3.79) 
and “I wasn’t sure how to express my thoughts” (autis-
tic vs. non-autistic OR = 3.45; possibly autistic vs. non-
autistic OR = 3.74), as reasons for non-disclosure (all 
Table 7 Inter‑correlations between all variables in the combined autistic/possibly autistic group, and the non‑autistic group
AQ = autism spectrum quotient; CAT-Q = camouflaging autistic traits—questionnaire; TB = thwarted belongingness; PB = perceived burdensomeness; ASA-A = autism 
anxiety scale—adult; PHQ-9 = patient health questionnaire—9 item; SBQ-R = suicide behaviours questionnaire—revised; SBQ-ASC = suicide behaviours 
questionnaire—autism spectrum conditions; NSSI = non-suicidal self-injury
** p < .01; * p < .05
AQ CAT-Q TB PB ASA-A PHQ-9 SBQ-R SBQ-ASC
Autistic and possibly autistic group
CAT‑Q .233**
TB .172** .067
PB .218** .193** .649**
ASA‑A .282** .453** .279** .485**
PHQ‑9 .181** .209** .568** .670** .585**
SBQ‑R .141** .197** .441** .634** .393** .573**
SBQ‑ASC .164** .232** .384** .631** .460** .545** .877**




PB .393** .445** .737**
ASA‑A .578** .568** .491** .483**
PHQ‑9 .425** .402** .574** .557** .607**
SBQ‑R .231** .298** .408** .543** .356** .466**
SBQ‑ASC .251** .312** .419** .530** .398** .543** .863**
NSSI .306** .259** .223** .301** .312** .325** .361** .411**
Table 8 Results of the receiver operating curve (ROC) analysis
Bold indicates the recommended SBQ-ASC cutoff correctly classifying 88% of autistic adults who reported lifetime experience of suicide attempt(s) according to item 
1 of the SBQ-R
Group SBQ-ASC cut-off Sensitivity Specificity AUC 95% CI
Autistic/possibly autistic ( N = 421) 11.5 0.867 0.74
12.5 0.822 0.81 .888 .855—.921
13.5 0.77 0.85
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Table 9 Comparison of individual item and total scores on the SBQ‑R and SBQ‑ASC between the autistic, possibly autistic and non‑
autistic groups
Autistic Possibly autistic Combined 
autistic/possibly 
autistic
Non-autistic Comparisons (autistic 
vs. possibly autistic vs. 
non-autistic)
N = 308 N = 113 N = 421 N = 268
N (%)/Mean (SD)
SBQ‑R mean item scores Lifetime suicidality 3.04 (.893) 2.66 (.935) 2.94 (.92) 2.11 (.965) H(2) = 119.05, p < .001
Frequency of suicidal 
thoughts in the past 
year
3.13 (1.59)n 2.78 (1.5)n 3.03 (1.57) 1.83 (1.21) H(2) = 101.35, p < .001
Suicide threat 1.78 (.865) 1.52 (.75) 1.71 (.841) 1.28 (.57) H(2) = 52.9, p < .001
Likelihood of future 
suicide attempt
2.85 (1.8) 2.08 (1.71) 2.65 (1.81) 1.06 (1.25) H(3) = 146.65, p < .001
Total SBQ‑R score 10.81 (4.05) 9.04 (3.9) 10.33 (4.08) 6.28 (3.08) ‑
 > Psychiatric cut‑off 230 (76.7) 48 (57.1) 294 (71.4) 183 (30.9) X2(2) = 119.27 p < .001, 
φ = .42
SBQ‑ASC visual aids Yes 117 (38) 35 (31) 152 (36.1) 59 (22) X2(2) = 17.21 p < .001, 
φ = .16
SBQ‑ASC item 1: lifetime 
suicidality
Non‑suicidal 19 (6.17) 10 (8.85) 29 (6.89) 81 (30.22)
Suicidal ideation—"brief 
passing thought"




41 (13.31) 13 (11.5) 54 (12.83) 40 (14.93)
Suicide plan 90 (29.22) 24 (21.24) 114 (27.08) 42 (15.67)
Suicide attempt 113 (36.69) 26 (23.01) 139 (33.02) 23 (8.58)
Mean item score 2.76 (1.26) 2.14 (1.35) 2.59 (1.31) 1.42 (1.3) H(2) = 125.98, p < .001
Lifetime suicide attempt 
subgroup follow‑up 
questions:
I had a plan that I carried 
out
66 (58.41) 12 (46.15) 78 (56.12) 10 (43.48) X2(2) = 2.74, p = .254, 
φ = .131
I had no plan 19 (16.81) 1 (3.85) 20 (14.39) 3 (13.04) X2(2) = 3, p = .223, φ = .136
I suddenly felt the urge 
to attempt to end my 
life (impulsivity)
44 (38.94) 12 (46.15) 56 (40.29) 12 (52.17) X2(2) = 1.49, p = .474, 
φ = .096
I happened to have 
access to the means to 
end my life
31 (27.43) 9 (34.62) 40 (28.78) 5 (21.74) X2(2) = 1.02, p = .6, φ = .08
SBQ‑ASC item 2: 
frequency of suicidal 
thoughts in last 
12 months
Never 90 (29.22) 39 (34.51) 129 (30.64) 173 (64.55)
Less than once a month 81 (26.3) 36 (31.86) 117 (27.79) 64 (23.88)
Once a month 29 (9.42) 16 (14.16) 45 (10.69) 13 (4.85)
2–3 times a month 32 (10.39) 8 (7.08) 40 (9.5) 8 (2.99)
Once a week 23 (7.47) 4 (3.54) 27 (6.41) 4 (1.49)
2–6 times a week 33 (10.71) 9 (7.96) 42 (9.98) 5 (1.87)
1 or more times a day 20 (6.49) 1 (0.88) 21 (4.99) 1 (0.37)
Mean item score 1.99 (1.96)n 1.41 (1.56)n 1.83 (1.88) .06 (1.09) H(2) = 100.25, p < .001
SBQ‑ASC item 3: duration 
of suicidal thoughts
N/A 57 (18.51) 34 (30.09) 91 (21.62) 146 (54.48)
Less than 5 min 38 (12.34) 22 (19.47) 60 (14.25) 46 (17.16)
Less than 1 h 71 (23.05) 22 (19.47) 93 (22.09) 27 (10.07)
1–4 h 73 (23.7) 19 (16.81) 92 (21.85) 30 (11.19)
5–8 h 29 (9.42) 7 (6.19) 36 (8.55) 5 (1.87)
More than 8 h 40 (12.99) 9 (7.96) 49 (11.64) 14 (5.22)
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Table 9 (continued)
Autistic Possibly autistic Combined 
autistic/possibly 
autistic
Non-autistic Comparisons (autistic 
vs. possibly autistic vs. 
non-autistic)
N = 308 N = 113 N = 421 N = 268
N (%)/Mean (SD)
Mean item score 2.32 (1.6) 1.73 (1.58) 2.16 (1.61) 1.04 (1.45) H(2) = 95.7, p < .001
SBQ‑ASC item 4: Likeli‑
hood of acting on 
suicidal thoughts
N/A 43 (13.96) 28 (24.78) 71 (16.86) 127 (47.39)
No chance at all 49 (15.91) 25 (22.12) 74 (17.58) 70 (26.12)
Very unlikely 95 (30.84) 42 (37.17) 137 (32.54) 45 (16.79)
Rather unlikely 90 (29.22) 17 (15.04) 107 (25.42) 25 (9.33)
Rather likely 27 (8.77) 1 (0.88) 28 (6.65) 1 (0.37)
Very likely 4 (1.3) 0 (0) 4 (0.95) 0 (0)
Mean item score 2.07 (1.21) 1.45 (1.05) 1.9 (1.2) .89 (1.02) H(2) = 128.38, p < .001
SBQ‑ASC item 5: commu‑
nication of suicidality 
to others
Suicidal ideation 186 (60.39) 50 (44.25) 236 (56.06) 82 (30.6)
Future suicide attempt 82 (26.62) 19 (16.81) 101 (23.99) 26 (9.7)
Past suicide attempt 110 (35.71) 24 (21.24) 134 (31.83) 26 (9.7)
Mean item score 2.21 (2.25) 1.42 (1.95) 1.99 (2.2) .79 (1.47) H(2) = 78.68, p < .001
Overall communication 
of suicidality
210 (68.2) 57 (50.4) 267 (63.4) 92 (34.3)
5b: Communicated sui‑
cidal intent subgroup: 
person(s) disclosed to
An acquaintance 5 (2.6) 4 (7.4) 9 (3.6) 3 (3.2) -
A friend 73 (37.2) 19 (35.2) 92 (36.8) 40 (42.6) X2(2) = 1.03, p = .6, φ = .05
A family member 75 (38.3) 17 (31.5) 92 (36.8) 37 (39.4) X2(2) = 1.02, p = .6, φ = .05




138 (70.4) 36 (63) 172 (68.8) 56 (62.3) X2(2) = 3.65, p = .16, φ = .1
Other 25 (12.8) 8 (14.8) 33 (13.2) 15 (16) X2(2) = .582, p = .75, φ = .04
5c: Non‑disclosure sub‑
group: reasons
I had no one to tell 22 (16.2) 4 (7.1) 26 (13.5) 6 (9) X2(2) = 3.95, p = .14, φ = .12
I chose not to 38 (27.9) 19 (33.9) 57 (29.7) 31 (46.3) X2(2) = 6.72, p = .035, 
φ = .16
I was worried about the 
effect on others
55 (40.4) 22 (39.3) 77 (40.1) 28 (41.8) X2(2) = 081, p = .96, φ = .02
I was worried about 
the consequences for 
myself
39 (28.7) 19 (33.9) 58 (30.2) 8 (11.9) X2(2) = 9.3, p = .01, φ = .19
I wasn’t sure how to 
express my thoughts
39 (28.7) 17 (30.4) 56 (29.2) 7 (10.4) X2(2) = 9.51, p = .009, 
φ = .19
I was afraid to 27 (19.9) 8 (14.3) 35 (18.2) 5 (7.5) X2(2) = 5.35, p = .07, φ = .14
I didn’t consider telling 
anyone
19 (14) 15 (26.8) 34 (17.7) 18 (26.9) X2(2) = 6.65, p = .036, 
φ = .16
Other (please specify): 17 (12.5) 7 (12.5) 24 (12.5) 4 (6) X2(2) = 2.2, p = .33, φ = .09
SBQ‑ASC item 6 (n = 602) Lifetime NSSI 160 (62.7) 45 (46.4) 205 (58.2) 66 (26.4) X2(2) = 67.46, p < .001, 
φ = .335
SBQ‑ASC Total score 11.34 (6.39) 8.15 (5.85) 10.5 (6.4) 4.75 (5.09) U = 12,308.5, p < .001*
 >  = SBQ‑ASC autism 
cut‑off
138 (44.8) 27 (23.9) 165 (39.2) 28 (10.4) X2(2) = 85.02 p < .001, 
φ = .35
n Denotes non-significant focused comparisons (autistic vs. possibly autistic groups); *Denotes focused comparison between autistic and possibly autistic total SBQ-
ASC scores
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p < 0.01). In the subgroup who reported lifetime history 
of NSSI (n = 602), autistic adults were significantly more 
likely to endorse lifetime experience of NSSI compared 
to possibly autistic (OR = 1.95) and non-autistic adults 
(OR = 4.69), and possibly autistic adults compared to 
non-autistic adults (OR = 2.41) (all p < 0.01).
Discussion
To our knowledge, no suicidality assessment tool has 
previously been developed and validated with and for 
autistic adults for use in research, despite this group 
being at high risk of experiencing suicidal thoughts and 
behaviours [16]. A previous study showed that a widely 
used suicidality assessment tool developed and vali-
dated for the general non-autistic population for use in 
research studies (the SBQ-R), was not interpreted and 
responded to in the same way by autistic adults, and did 
not include items relevant to autistic adults’ experience 
of suicidality (e.g. perseverative suicidal thoughts, impul-
sive suicide attempts without a plan, why suicidality had 
not been disclosed to others) [26]. We therefore adapted 
the SBQ-R with and for autistic adults, and subsequently 
tested the measurement properties of the adapted SBQ-
ASC, in autistic, possibly autistic and non-autistic adults. 
Our results show support for a range of measurement 
properties of the SBQ-ASC for use in research studies 
with autistic/possibly autistic adults. The SBQ-ASC can 
be freely downloaded from: https:// sites. google. com/ 
view/ menta lheal thina utism/ resou rces/ tools.
Results show support for content validity of the SBQ-
ASC in autistic/possibly autistic adults, with high rat-
ings in support of the clarity of the adapted items (> 0.8). 
Cognitive interviews confirmed that autistic adults inter-
preted and responded to the adapted items as intended. 
Results subsequently showed support for the struc-
tural validity and internal consistency of the SBQ-ASC 
in autistic, possibly autistic and non-autistic adults. 
Exploratory and confirmatory factor analyses (in inde-
pendent samples) showed excellent fit to a single factor 
structure for the SBQ-ASC in autistic, possibly autistic, 
and non-autistic adults, with acceptable internal con-
sistency (> 0.79) in each group. There was evidence of a 
different baseline model in the combined autistic/pos-
sibly autistic group compared to the non-autistic group, 
indicating that the structure of the SBQ-ASC is different 
in these groups. There was evidence in support of meas-
urement invariance (i.e. equivalence) of the SBQ-ASC in 
autistic compared to possibly autistic adults, males com-
pared to females, and use of visual aids to help quantify 
response options for item 4 (e.g. no chance at all, and 
rather likely), in autistic/possibly autistic and non-autis-
tic adults. This indicates that SBQ-ASC total scores can 
be compared and/or combined between autistic people 
with or without a confirmed diagnosis, across genders, 
and use of visual aids for item 4. However, total scores 
on the SBQ-ASC cannot be compared between autistic 
and non-autistic adults, given evidence for a different 
baseline model between these groups. The SBQ-ASC also 
showed excellent stability of scores, with strong correla-
tions (> 0.9) between SBQ-ASC total scores pre/post a 
2-week gap in autistic/possible autistic, and non-autistic 
adults.
There was evidence in support of convergent validity, 
with the SBQ-ASC significantly correlating with known 
risk markers for suicidality (autistic traits, camouflaging, 
thwarted belongingness and perceived burdensomeness, 
current anxiety and depressive symptoms, and lifetime 
NSSI), in both autistic/possibly autistic adults, and non-
autistic adults. There was also evidence in support of 
divergent validity. Specifically, the ASA-A, an anxiety 
measure designed to more accurately identify anxiety in 
autistic adults [42], was significantly more strongly cor-
related with the SBQ-ASC (a measure also designed 
with and for autistic adults), compared to the SBQ-R (a 
measure designed for non-autistic adults). Autistic traits 
(AQ) and camouflaging autistic traits (CAT-Q), were also 
both more strongly correlated with the SBQ-ASC than 
with the SBQ-R, but these differences were not statisti-
cally significant. This suggests that the SBQ-ASC is more 
sensitive to detecting associations with autism relevant 
constructs compared to the original version of the tool, 
and is therefore more appropriate for use in suicidality 
research in autistic/possibly autistic samples than the 
original version.
There was further evidence of divergent validity, indi-
cating that the SBQ-ASC is also sensitive to detecting dif-
ferences in the strength of associations between proximal 
compared to more distally related constructs. The SBQ-
ASC was significantly more strongly correlated with the 
original version measuring the same construct of suici-
dality (SBQ-R), compared to more proximal risk mark-
ers for suicidality (thwarted belongingness, perceived 
burdensomeness, depression and anxiety). The SBQ-ASC 
was also significantly more strongly correlated with more 
proximal risk markers for suicidality (depression/anxi-
ety) than more distal risk markers (autistic traits). These 
results suggest that the SBQ-ASC could be particularly 
useful in modelling studies aiming to identify and distin-
guish proximal/distal risk markers for suicidal thoughts 
and behaviours in autistic/possibly autistic people—a 
crucial and underexplored area of research prioritised by 
the autism community [23, 24].
An indicative cut-off on the SBQ-ASC for distin-
guishing autistic/possibly autistic adults, with or with-
out a lifetime history of suicide attempt(s), is 12.5. This 
cut-off showed excellent sensitivity and specificity, 
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correctly classifying 88% of autistic/possibly autistic 
adults who self-reported lifetime experience of suicide 
attempt(s) using item 1 of the original SBQ-R as the cri-
terion. This follows the recommendation of COSMIN (a 
validated research tool used to assess the methodologi-
cal quality of studies exploring evidence for and against 
the measurement properties of health outcome assess-
ment tools), to use the original version of an assessment 
tool as the ‘gold standard’ criterion on which to assess 
sensitivity and specificity [50]. This cut-off is appropri-
ate to use in research studies to categorise autistic/pos-
sibly autistic adults in a sample at a higher/lower risk 
of lifetime suicide attempt(s), to help establish preva-
lence, and compare subgroups within the wider sample. 
However, this cut-off is not appropriate to be used in 
the context of treatment decisions or classifying autis-
tic/possibly autistic people as high or low risk of future 
suicide attempts in clinical practice. The reasons being 
that first, this cut-off has been calculated in the context 
of research and past (not future) suicide attempt(s), and 
second, there is strong evidence that short suicide risk 
assessment tools like the SBQ-ASC and SBQ-R do not 
help clinicians correctly identify who will likely attempt 
suicide in the future [19–21].
The SBQ-ASC showed evidence in support of hypoth-
esis testing. As predicted, autistic/possibly autistic 
adults scored significantly higher on each item of the 
SBQ-ASC than non-autistic adults. Interestingly, total 
scores on the SBQ-ASC were significantly higher in 
autistic compared to possibly autistic adults. The SBQ-
ASC also shows strong potential for increasing our 
understanding of how suicidal thoughts and behaviours 
present in autistic/possibly autistic adults. Across the 
interviews and online surveys, autistic adults reported 
presence of perseverative suicidal thoughts, and impul-
sive suicide attempts without necessarily having a plan 
when the means to self-harm were present [26]. Autis-
tic people also reported that they found it difficult to 
disclose their suicidal thoughts and behaviours to oth-
ers, because of communication difficulties, social iso-
lation, and lack of access to support. The SBQ-ASC 
includes optional items to explore and compare these 
experiences between groups. Contrary to our predic-
tions, in the subgroup who reported lifetime experience 
of suicide attempts, there were no significant differ-
ences between autistic, possibly autistic and non-autis-
tic adults in having a suicide plan, impulsivity or access 
to means. In the subgroup who had communicated sui-
cidality to others, there were no significant differences 
between the groups in who was told (e.g. acquaint-
ance, friend, family, professional). However, this may 
have been because of the lifetime focus of these ques-
tions, and possible measurement differences between 
items. Future research could ask these questions about 
specific instances of contemplating and/or attempting 
suicide, to compare the characteristics and patterns of 
suicidal thoughts and behaviours between autistic and 
non-autistic people.
Importantly, and in line with our hypotheses, in the 
subgroup who had never disclosed suicidality to oth-
ers, autistic and possibly autistic adults were signifi-
cantly more likely to report being worried about the 
consequences for themselves, and not being sure how 
to express their thoughts compared to non-autistic peo-
ple. Previous research shows that autistic people experi-
ence high anxiety, and part of the reason is intolerance 
of uncertainty in the future [60]. In our interviews with 
autistic people, many reported anxiety about the pur-
poses of assessments for suicidal thoughts and behav-
iours, and what would happen next. Communication 
difficulties are required for a diagnosis of autism [44], and 
autistic people can also experience difficulties verbalising 
their own internal thoughts and feelings (termed Alexy-
thymia) [61]. Many autistic people in our interviews also 
described finding it difficult to communicate their suici-
dality to others, but nevertheless experiencing suicidality. 
Findings from the current study are consistent with these 
experiences, and show evidence of possibly different 
reasons for non-disclosure in autistic compared to non-
autistic people. Importantly, the top reason for non-dis-
closure across all groups was worry about the impact of 
disclosing suicidality on others. Recent research has chal-
lenged assumptions of lack of empathy in autistic people 
[62, 63], and clinicians should not assume that this is not 
a similar obstacle to disclosure in autistic people.
There are clear implications for research and clinical 
practice. The SBQ-ASC is the first suicidality assessment 
tool developed and validated with and for autistic/possi-
bly autistic adults for use in research. We would caution 
against using the SBQ-ASC alone to inform treatment 
decisions or to assess risk of future suicide attempts (see 
above) [22]. However, the SBQ-ASC could be helpful to 
clinicians in starting to identify presence of lifetime sui-
cidal thoughts and behaviours, and suicidal thoughts 
in the past year, in autistic/possibly autistic adults. The 
optional follow-up questions included in the SBQ-ASC 
could also help clinicians gain useful initial information 
about previous suicide attempts (planning, impulsivity 
and access to means), whether and who the person has 
ever told about their suicidality, and reasons for non-
disclosure, to start important conversations about possi-
ble support and safety planning (e.g. ways of alerting key 
people to suicidal crises, facilitating access to relevant 
support and social networks, addressing concerns and 
answering questions about what would happen in the 
event of reporting suicidal thoughts and/or behaviours). 
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Clinicians should be aware of the different experience 
of suicidality in autistic people, who appear more likely 
to experience perseverative suicidal thoughts than non-
autistic people. Broadly, clinicians should be aware that 
autistic/possibly autistic people are potentially more 
likely to be concerned about what will happen to them 
if they disclose their suicidality to others, have signifi-
cantly more difficulty in knowing how to communicate 
their suicidal thoughts and intent to another person, and 
be concerned about the potential impact of disclosure 
on others. These likely present barriers to help seeking, 
and clinicians should therefore take the initiative and ask 
autistic people and those with high autistic traits (but not 
diagnosed) if they are experiencing suicidality.
A key strength of this study and broader program 
of work developing the SBQ-ASC, is the involvement 
of autistic people in first identifying the need for the 
research [23, 24], identifying potential issues with the 
original version [26], and co-producing adaptations in the 
current study. Assessing the appropriateness and meas-
urement properties of the SBQ-ASC followed recom-
mended best practice according to a validated research 
tool used to assess the quality of evidence for and against 
the measurement properties of health outcome assess-
ment tools (COSMIN) [50]. COSMIN argues that con-
tent validity is the most important foundational property 
on which all other measurement properties rely on—if a 
tool is not relevant or clear to the target group, then it 
is unlikely to adequately capture the intended construct 
in that group. Despite this, few studies conduct exten-
sive work to establish content validity of tools in groups, 
using rigorous methods such as participatory approaches 
[26, 64, 65] or cognitive interviewing [66]. In contrast, 
we conducted extensive work to ensure that the adapted 
SBQ-ASC captured the unique experience of suicidality 
in autistic and possibly autistic adults, prior to finalis-
ing the tool and assessing its measurement properties in 
autistic, possibly autistic and non-autistic adults. We also 
followed other key recommendations, such as using sep-
arate samples to explore and confirm the factor structure 
of the tool between groups, with at least 7 participants 
per item and over 100 participants total, and used the 
original version of the tool as the ‘gold standard’ crite-
rion to assess sensitivity and specificity [50]. Results from 
the current study suggest that ensuring content validity 
increases the sensitivity of the new tool to detecting asso-
ciations with relevant constructs (i.e. autistic traits).
In research, tools tend to be validated in one group, but 
used in many others, without necessarily testing whether 
the tool operates similarly between the groups being 
studied. Another key strength of the current study was 
testing whether the SBQ-ASC operates similarly between 
autistic/possibly autistic, and non-autistic adults. Results 
suggest important measurement differences between 
autistic/possibly autistic adults, compared to non-autistic 
adults. This is consistent with previous research show-
ing that autistic adults do not interpret or respond as 
intended by the tool developers to the original version 
of the SBQ-R [26], or tools developed for non-autistic 
people more generally [65]. Key adaptations to the SBQ-
ASC, informed from our previous research [26] and cur-
rent study, included simplifying and clarifying response 
options, including visual aids to help quantify abstract 
response options (e.g. rarely, very likely), and includ-
ing new items to capture the full range of frequency and 
duration of suicidal thoughts (up to every day, and over 
8  h duration) reported by autistic adults. These adapta-
tions follow best practice guidelines for adapting scales 
with and for autistic people [65], with new items devel-
oped to better capture autistic adults’ unique experiences 
of suicidality, not included in any previous measures 
designed for other groups. Results from the measure-
ment invariance analysis therefore that suggest autistic 
people experience suicidality differently to non-autistic 
people, and this experience is not accurately captured 
in previous measures designed for non-autistic people. 
Future research must further explore autistic people’s 
unique experiences of constructs such as suicidality and 
mental health, to inform a broader suite of tools which 
better capture these constructs in different contexts, 
including clinical practice.
Limitations
The study sample and wider program of work developing 
the SBQ-ASC included a high proportion of females, who 
were largely diagnosed in adulthood or were awaiting 
assessment. Participation involved interviews and com-
pleting online surveys. Therefore, results are likely not 
generalisable to autistic adults diagnosed in childhood, 
or with co-occurring intellectual disability. However, 
there is evidence that autistic women are at significantly 
increased risk of death by suicide compared to non-autis-
tic women [6–8], and are more likely to experience delay 
in diagnosis due to lack of appropriate autism assess-
ment tools validated for females [11]. Given the focus of 
the current study on developing an appropriate tool to 
effectively identify suicidal thoughts and behaviours in 
autistic/possibly autistic adults in research studies, it was 
crucial to include a large sample of women, which have 
been traditionally under-represented in autism research 
[67]. There were also sufficient numbers of males and 
females in the current study to establish equivalence of 
the adapted SBQ-ASC across gender according to best 
practice guidelines for the analyses [50]. Hence, the SBQ-
ASC has been validated for both autistic and possibly 
autistic males and females. Adults without co-occurring 
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intellectual disability, and/or diagnosed in adulthood, are 
at particularly high risk of suicidal thoughts and behav-
iours [3, 9] and death by suicide [6]. This suggests that the 
SBQ-ASC is particularly appropriate for identification 
and modelling of risk markers for suicidality in this group 
at relatively high risk of suicidality. However, future 
research will need to explore whether the SBQ-ASC is 
also appropriate for autistic people diagnosed in child-
hood, and/or co-occurring intellectual disability. Autism 
diagnostic status was confirmed through self-report. The 
possibly autistic group also consisted of those who self-
identified as autistic, without a diagnosis. Future research 
could also include possibly autistic people who are sus-
pected to be autistic by others (e.g. by family and friends).
The SBQ-ASC has been developed and validated for 
use in research. The SBQ-ASC has not been validated 
and there is no evidence in support of predicting future 
adverse events including suicide attempts using scores 
from this tool. The SBQ-ASC assesses lifetime experience 
of suicidal thoughts and behaviours, frequency of suicidal 
thoughts in the past year, duration of suicidal thoughts, 
likelihood of future suicide attempt, and communication 
of suicidal thoughts and behaviours to others. The SBQ-
ASC does not however capture current suicidal thoughts. 
Further work will therefore be necessary to develop a 
range of suicidality assessment tools appropriate for dif-
ferent subgroups and contexts, including autistic chil-
dren and youth, with or without intellectual disability, in 
research and clinical practice.
Conclusion
We present a new tool developed and validated with 
and for autistic and possibly autistic adults, to more 
accurately capture suicidality in these groups in 
research studies—the SBQ-ASC. The SBQ-ASC was 
adapted from a well validated and widely used suicidal-
ity assessment tool originally developed for the general 
population for use in research studies (the SBQ-R) [25, 
26]. The SBQ-ASC has evidence in support of a range 
of measurement properties, including content valid-
ity, structural validity, internal consistency, test–retest 
validity, convergent and divergent validity, criterion 
validity, and hypothesis testing. There is also evidence 
in support of the structural equivalence of the SBQ-
ASC in autistic compared to possibly autistic adults, 
regardless of gender, and use of visual aids to assist with 
quantification of abstract response options for item 4 
(e.g. likely vs. very likely). The SBQ-ASC is therefore 
recommended to identify suicidal thoughts, behav-
iours and characteristics in autistic adults (diagnosed 
or undiagnosed), without co-occurring intellectual dis-
ability, in research to help model risk factors for sui-
cidality and associated characteristics. The SBQ-ASC 
could also be useful in clinical practice to help iden-
tify lifetime suicidal thoughts and behaviours, and past 
year suicidal thoughts, characteristics (plans, impul-
sivity, access to means, reasons for non-disclosure), 
and to start conversations about needed support (e.g. 
with removing access to means, and with help seek-
ing in a crisis). However, results also suggest that the 
SBQ-ASC is not appropriate for comparing total scores 
between autistic/possibly autistic adults, with non-
autistic adults given measurement differences between 
these groups. These findings suggest that autistic peo-
ple experience suicidality differently to non-autistic 
people, and future research must further develop tools 
with and for autistic/possibly autistic adults, to better 
understand and capture unique experiences of suicidal-
ity and associated risk markers.
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